Publication | Closed Access
Depletion of functionally active CD20+ T cells by rituximab treatment
149
Citations
19
References
2009
Year
These findings suggest that CD20+ T cells represent a terminally differentiated cell type with immune-regulatory and proinflammatory capacities. Depletion of CD20+ T cells may be an additional mechanism by which anti-CD20 therapy functions in patients with RA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1